Underlying comorbid illness is a known risk factor for severe coronavirus disease- 2019 (COVID-19). Clinical course of COVID-19 in children with primary kidney disease is not well understood. We present the clinical profile and management of COVID-19 in three children at a COVID hospital in India. These children had nephrotic syndrome, hemolytic uremic syndrome, and chronic kidney disease, respectively. The first two were immunosuppressed, mandating to stop their immunosuppressive medications temporarily. Both had mild course of illness. Third child presented with respiratory distress requiring oxygen support, falling into moderate disease. Renal functions were normal in all of them. They all responded well to oral azithromycin and supportive management. None of them received chloroquine, corticosteroids, or monoclonal antibodies. All three recovered without complications.
CITATION STYLE
Meshram, A., Vala, K. B., Saha, A., Patel, H. V., Kute, V., & Gera, D. (2021). Coronavirus disease-2019 in children with primary kidney disease: A case series. Saudi Journal of Kidney Diseases and Transplantation, 32(1), 218–222. https://doi.org/10.4103/1319-2442.318527
Mendeley helps you to discover research relevant for your work.